The OneStart Americas competition, a partnership between Oxbridge Biotech Roundtable and SR One, the venture capital arm of GlaxoSmithKline, officially launched on November 4 at UCSF. The kick-off event was followed by similar events held this month in Los Angeles, San Diego and Boston.
OneStart Americas invites individuals or teams of burgeoning life science entrepreneurs under 36 years of age to apply in one of four tracks: drug discovery, medical devices, diagnostics, or health information technology. 35 selected semi-finalists will undergo two-months of extensive mentorship from venture capitalists, pharmaceutical executives, and other entrepreneurs in order to turn their idea into a comprehensive business plan.